{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:43:06Z","timestamp":1792010586417,"version":"4.4.0"},"reference-count":85,"publisher":"Bioscientifica","issue":"2","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Von Hippel-Lindau (VHL) disease is a dominantly inherited familial cancer syndrome caused by mutations in the VHL tumour suppressor gene. VHL disease is characterised by marked phenotypic variability and the most common tumours are haemangioblastomas of the retina and central nervous system and clear cell renal cell carcinoma. However, endocrine tumours, most commonly phaeochromocytoma and non-secretory pancreatic islet cell cancers, demonstrate marked interfamilial variations in frequency and are significant causes of morbidity and, sometimes, mortality. Genotype\u2013phenotype correlations have revealed that certain missense mutations are associated with a high risk of phaeochromocytoma but total loss of function mutations are associated with a low risk. Furthermore, rare mutations may predispose to a phaeochromocytoma-only phenotype. Germline VHL mutations may be detected in 5\u201311% of all phaeochromocytoma cases and mutation analysis of VHL and other phaeochromocytoma susceptibility genes (SDHB, SDHD and RET) should be performed in all cases of familial, multiple or early onset phaeochromocytomas, and considered in other cases. The VHL gene product has a key role in regulating the stability of hypoxia-inducible factors (HIF-1 and HIF-2) such that inactivation of VHL leads to up-regulation of HIF-1 and HIF-2 protein expression and activation of hypoxic gene response pathways. Germline SDHB and SDHD mutations also lead to increased expression of HIF target genes, but it appears that phaeochromocytoma susceptibility in VHL disease cannot be attributed to HIF activation alone. Recently, it has been suggested that an HIF-independent failure of developmental apoptosis is a common feature of all inherited phaeochromocytoma susceptibility syndromes.<\/jats:p>","DOI":"10.1677\/erc.1.00683","type":"journal-article","created":{"date-parts":[[2006,5,25]],"date-time":"2006-05-25T14:29:44Z","timestamp":1148567384000},"page":"415-425","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":61,"title":["Von Hippel-Lindau disease and endocrine tumour susceptibility"],"prefix":"10.1530","volume":"13","author":[{"given":"Emma R","family":"Woodward","sequence":"first","affiliation":[{"name":"Section of Medical and Molecular Genetics and Cancer Research UK Renal Molecular Oncology Group, University of Birmingham, Institute of Biomedical Research, Birmingham B15 2TT, UK and West Midlands Regional Genetics Service, Birmingham Women\u2019s Hospital, Birmingham B15 2TG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn R","family":"Maher","sequence":"additional","affiliation":[{"name":"Section of Medical and Molecular Genetics and Cancer Research UK Renal Molecular Oncology Group, University of Birmingham, Institute of Biomedical Research, Birmingham B15 2TT, UK and West Midlands Regional Genetics Service, Birmingham Women\u2019s Hospital, Birmingham B15 2TG, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2026070905580032600_ACKER-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Acker\n            T\n          , Diez-Juan A, Aragones J, Tjwa M, Brusselmans K, Moons L, Fukumura D, Moreno-Murciano MP, Herbert JM, Burger A, Riedel J, Elvert G, Flamme I, Maxwell PH, Collen D, Dewerchin M, Jain RK, Plate KH & Carmeliet P 2005 Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell8131\u2013141.","DOI":"10.1016\/j.ccr.2005.07.003"},{"key":"2026070905580032600_ANG-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Ang\n            SO\n          , Chen H, Hirota K, Gordeuk VR, Jelinek J, Guan Y, Liu E, Sergueeva AI, Miasnikova GY, Mole D et al.2002 Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nature Genetics32614\u2013621.","DOI":"10.1038\/ng1019"},{"key":"2026070905580032600_ARAO-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Arao\n            T\n          , Okada Y, Tanikawa T, Inatomi H, Shuin T, Fujihira T, Yamashita H & Tanaka Y 2002 A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism. Endocrinology Journal49181\u2013188.","DOI":"10.1507\/endocrj.49.181"},{"key":"2026070905580032600_ASTUTI-ETAL-2001A","doi-asserted-by":"crossref","unstructured":"Astuti\n            D\n          , Douglas F, Lennard TWJ, Aligianis I, Woodward ER, Evans DGR, Eng C, Latif F & Maher ER 2001a Germline SDHD mutation in familial phaeochromocytoma. Lancet3571181\u20131182.","DOI":"10.1016\/S0140-6736(00)04378-6"},{"key":"2026070905580032600_ASTUTI-ETAL-2001B","unstructured":"Astuti\n            D\n          , Latif F, Dallol A, Dahia PLM, Douglas F, George E, Skoldberg F, Husebye ES, Eng C & Maher ER 2001b Mutations in the mitochondrial complex II subunit SDHB cause susceptibility to familial paraganglioma and pheochromocytoma. American Journal of Human Genetics6949\u201354."},{"key":"2026070905580032600_ASTUTI-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Astuti\n            D\n          , Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C, Moran A, Grossman AB, Hodgson S, Freemont A et al.2003 Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clinical Endocrinology59728\u2013733.","DOI":"10.1046\/j.1365-2265.2003.01914.x"},{"key":"2026070905580032600_BAYSAL-ETAL-2000","unstructured":"Baysal\n            BE\n          , Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Tashner PE, Rubinstein WS, Myers EN et al.2000 Mutations in SDHD, a mitochondrial complex II gene in hereditary paraganglioma. Science287848\u2013851."},{"key":"2026070905580032600_BINKOVITZ-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Binkovitz\n            LA\n          , Johnson CD & Stephens DH 1990 Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias. American Journal of Roentgenology1621091\u20131094.","DOI":"10.2214\/ajr.155.3.1974734"},{"key":"2026070905580032600_BRAUCH-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Brauch\n            H\n          , Kishida T, Glavac D, Chen F, Pausch F, Hofler H, Latif F, Lerman MI, Zbar B & Neumann HPH 1995 Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Human Genetics95551\u2013556.","DOI":"10.1007\/BF00223868"},{"key":"2026070905580032600_BRUICK-AND-MCKNIGHT-2001","doi-asserted-by":"crossref","unstructured":"Bruick\n            RK\n           & McKnight SL 2001 A conserved family of prolyl-4-hydroxylases that modify HIF. Science2941337\u20131340.","DOI":"10.1126\/science.1066373"},{"key":"2026070905580032600_CHEN-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Chen\n            F\n          , Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G et al.1995 Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Human Mutation566\u201375.","DOI":"10.1002\/humu.1380050109"},{"key":"2026070905580032600_CLIFFORD-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Clifford\n            SC\n          , Cockman ME, Smallwood AC, Mole DR, Woodward ER, Maxwell PH, Ratcliffe PJ & Maher ER 2001 Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumorigenesis in von Hippel-Lindau disease. Human Molecular Genetics101029\u20131038.","DOI":"10.1093\/hmg\/10.10.1029"},{"key":"2026070905580032600_COCKMAN-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Cockman\n            ME\n          , Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ & Maxwell PH 2000 Hypoxia-inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. Journal of Biological Chemistry27525733\u201325741.","DOI":"10.1074\/jbc.M002740200"},{"key":"2026070905580032600_CROSSEY-ETAL-1994","unstructured":"Crossey\n            PA\n          , Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Ferguson-Smith MA et al.1994 Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Human Molecular Genetics31303\u20131308."},{"key":"2026070905580032600_CROSSEY-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Crossey\n            PA\n          , Eng C, Ginalska-Malinowska M, Lennard TWJ, Sampson JR, Ponder BAJ & Maher ER 1995 Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma. Journal of Medical Genetics32885\u2013886.","DOI":"10.1136\/jmg.32.11.885"},{"key":"2026070905580032600_DAHIA-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Dahia\n            PL\n          , Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS et al.2005 A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. Public Library of Science Genetics172\u201380.","DOI":"10.1371\/journal.pgen.0010008"},{"key":"2026070905580032600_DECHANT-2002","unstructured":"Dechant\n            G\n          \n          2002 Chat in the trophic web: NGF activates Ret by inter RTK signalling. Neuron33156\u2013158."},{"key":"2026070905580032600_DEVARAJAN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Devarajan\n            P\n          , De Leon M, Talasazan F, Schoenfeld AR, Davidowitz EJ & Burk RD 2001 The von Hippel-Lindau gene product inhibits renal cell apoptosis via Bcl-2-dependent pathways. Journal of Biological Chemistry27640599\u201340605.","DOI":"10.1074\/jbc.M103424200"},{"key":"2026070905580032600_EISENHOFER-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Eisenhofer\n            G\n          , Walther MM, Huynh TT, Li ST, Bornstein SR, Vortmeyer A, Mannelli M, Goldstein DS, Linehan WM, Lenders JW et al.2001 Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes. Journal of Clinical Endocrinology and Metabolism861999\u20132008.","DOI":"10.1210\/jcem.86.5.7496"},{"key":"2026070905580032600_EISENHOFER-ETAL-2004","doi-asserted-by":"crossref","unstructured":"Eisenhofer\n            G\n          , Huynh TT, Pacak K, Brouwers FM, Walther MM, Linehan WM, Munson PJ, Mannelli M, Goldstein DS & Elkahloun AG 2004 Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome. Endocrine-Related Cancer11897\u2013911.","DOI":"10.1677\/erc.1.00838"},{"key":"2026070905580032600_ENG-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Eng\n            C\n          , Crossey PA, Mulligan LM, Healey CS, Houghton C, Prowse A, Chew SL, Dahia PL, O\u2019Riordan JL, Toledo SP et al.1995 Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas. Journal of Medical Genetics32934\u2013937.","DOI":"10.1136\/jmg.32.12.934"},{"key":"2026070905580032600_EPSTEIN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Epstein\n            AC\n          , Gleadle JM, McNeill LA, Hewitson KS, O\u2019Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A et al.2001C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell10743\u201354.","DOI":"10.1016\/S0092-8674(01)00507-4"},{"key":"2026070905580032600_ESTUS-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Estus\n            S\n          , Zaks WJ, Freeman RS, Gruda M, Bravo R & Johnson EM Jr 1994 Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. Journal of Cell Biology1271717\u20131727.","DOI":"10.1083\/jcb.127.6.1717"},{"key":"2026070905580032600_FELLOWS-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Fellows\n            IW\n          , Leach IH, Smith PG, Toghill PJ & Doran J 1990 Carcinoid tumour of the common bile duct \u2013 a novel complication of von Hippel-Lindau syndrome. Gut31728\u2013729.","DOI":"10.1136\/gut.31.6.728"},{"key":"2026070905580032600_FOSTER-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Foster\n            K\n          , Prowse A, van den Berg A, Fleming S, Hulsbeek MM, Crossey PA, Richards FM, Cairns P, Affara NA, Ferguson-Smith MA et al.1994 Somatic mutations of the von Hippel\u2013Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma. Human Molecular Genetics32169\u20132173.","DOI":"10.1093\/hmg\/3.12.2169"},{"key":"2026070905580032600_GIMENEZ-ROQUEPLO-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Gimenez-Roqueplo\n            AP\n          , Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, Rotig A & Jeunemaitre X 2001 The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. American Journal of Human Genetics691186\u20131197.","DOI":"10.1086\/324413"},{"key":"2026070905580032600_GIMENEZ-ROQUEPLO-ETAL-2003","unstructured":"Gimenez-Roqueplo\n            AP\n          , Favier J, Rustin P, Rieubland C, Crespin M, Nau V, Khau Van Kien P, Corvol P, Plouin PF, Jeunemaitre X et al.2003 Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas. Cancer Research635615\u20135621."},{"key":"2026070905580032600_GLUSHIEN-ETAL-1953","unstructured":"Glushien\n            AS\n          , Mansuy MM & Littman DS 1953 Pheochromocytoma. Its relationship to the neurocutaneous syndromes. American Journal of Medicine14318\u2013327."},{"key":"2026070905580032600_GNARRA-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Gnarra\n            JR\n          , Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh FM et al.1994 Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genetics785\u201390.","DOI":"10.1038\/ng0594-85"},{"key":"2026070905580032600_GRIMM-ETAL-2000","unstructured":"Grimm\n            O\n          , Armanios M, Dziema H, Neumann HPH & Eng C 2000 Somatic and occult germline mutations in SDHD, a mitochondrial complex II gene, in non-familial pheochromoctyoma. Cancer Research606822\u20136825."},{"key":"2026070905580032600_HAM-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Ham\n            J\n          , Babij C, Whitfiels J, Pfarr CM, Lallemand D, Yaniv M & Rubin LL 1995 A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron14927\u2013939.","DOI":"10.1016\/0896-6273(95)90331-3"},{"key":"2026070905580032600_HAMMEL-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Hammel\n            PR\n          , Vilgrain V, Terris B, Penfornis A, Sauvanet A, Correas JM, Chauveau D, Balian A, Beigelman C, O\u2019Toole D et al.2000 Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d\u2019Etude de la Maladie de von Hippel-Lindau. Gastroenterology1191087\u20131095.","DOI":"10.1053\/gast.2000.18143"},{"key":"2026070905580032600_HERGOVICH-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Hergovich\n            A\n          , Lisztwan J, Barry R, Ballschmieter P & KrekW 2003 Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL. Nature Cell Biology564\u201370.","DOI":"10.1038\/ncb899"},{"key":"2026070905580032600_HOFFMAN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Hoffman\n            MA\n          , Ohh M, Yang H, Klco JM, Ivan M & Kaelin WG Jr 2001 von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Human Molecular Genetics101019\u20131027.","DOI":"10.1093\/hmg\/10.10.1019"},{"key":"2026070905580032600_HOUGH-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Hough\n            MT\n          , Stephens DH, Johnson CD & Binkovitz LA 1994 Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. American Journal of Roentgenology1621091\u20131094.","DOI":"10.2214\/ajr.162.5.8165988"},{"key":"2026070905580032600_IVAN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Ivan\n            M\n          , Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS & Kaelin WG Jr 2001 HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science292464\u2013468.","DOI":"10.1126\/science.1059817"},{"key":"2026070905580032600_JAAKKOLA-ETAL-2001","unstructured":"Jaakkola\n            P\n          , Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ et al.2001 Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science292468\u2013472."},{"key":"2026070905580032600_KAMURA-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Kamura\n            T\n          , Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS, Kaelin WG Jr, Elledge SJ, Conaway RC et al.1999 Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase. Science284657\u2013661.","DOI":"10.1126\/science.284.5414.657"},{"key":"2026070905580032600_KANNO-ETAL-1994","unstructured":"Kanno\n            H\n          , Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Shuin T & Yao M 1994 Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Research544845\u20134847."},{"key":"2026070905580032600_KONDO-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Kondo\n            K\n          , Klco J, Nakamura E, Lechpammer M & Kaelin WG Jr 2002 Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell1237\u2013246.","DOI":"10.1016\/S1535-6108(02)00043-0"},{"key":"2026070905580032600_LATIF-ETAL-1993","doi-asserted-by":"crossref","unstructured":"Latif\n            F\n          , Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al.1993 Identification of the von Hippel-Lindau disease tumour suppressor gene. Science2601317\u20131320.","DOI":"10.1126\/science.8493574"},{"key":"2026070905580032600_LEE-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Lee\n            S\n          , Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin WG Jr et al.2005 Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial phaeochromocytoma genes: developmental culling and cancer. Cancer Cell81\u201313.","DOI":"10.1016\/j.ccr.2005.06.015"},{"key":"2026070905580032600_LIBUTTI-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Libutti\n            SK\n          , Choyke PL, Bartlett DL, Vargas H, Walther M, Lubensky I, Glenn G, LinehanWM& Alexander HR 1998 Pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease: diagnostic and management recommendations. Surgery1241153\u20131159.","DOI":"10.1067\/msy.1998.91823"},{"key":"2026070905580032600_LIBUTTI-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Libutti\n            SK\n          , Choyke PL, Alexander HR, Glenn G, Bartlett DL, Zbar B, Lubensky I, McKee SA, Maher ER & Linehan WM 2000 Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. Surgery1281022\u20131027.","DOI":"10.1067\/msy.2000.110239"},{"key":"2026070905580032600_LIPSCOMB-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Lipscomb\n            E\n          , Sarmiere P, Crowder R & Freeman R 1999 Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons. Journal of Neurochemistry73429\u2013432.","DOI":"10.1046\/j.1471-4159.1999.0730429.x"},{"key":"2026070905580032600_LIPSCOMB-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Lipscomb\n            E\n          , Sarmiere P & Freeman R 2001 SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. Journal of Biological Chemistry27611775\u201311782.","DOI":"10.1074\/jbc.M008407200"},{"key":"2026070905580032600_LONERGAN-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Lonergan\n            KM\n          , Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW & Kaelin WG Jr 1998 Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B\/C and Cul2. Molecular and Cellular Biology18732\u2013741.","DOI":"10.1128\/MCB.18.2.732"},{"key":"2026070905580032600_LUBENSKY-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Lubensky\n            IA\n          , Pack S, Ault D, Vortmeyer AO, Libutti AK, Choyke PL, Walther McCM, Linehan WM & Xhaung Z 1998 Mulitple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients. American Journal of Pathology153223\u2013231.","DOI":"10.1016\/S0002-9440(10)65563-0"},{"key":"2026070905580032600_MAHER-2004","doi-asserted-by":"crossref","unstructured":"Maher\n            ER\n          \n          2004 Von Hippel-Lindau disease. Current Molecular Medicine4833\u2013842.","DOI":"10.1093\/oso\/9780192631466.003.0021"},{"key":"2026070905580032600_MAHER-AND-ENG-2002","doi-asserted-by":"crossref","unstructured":"Maher\n            ER\n           & Eng C 2002 The pressure rises: update in the genetics of phaeochromocytoma. Human Molecular Genetics112347\u20132354.","DOI":"10.1093\/hmg\/11.20.2347"},{"key":"2026070905580032600_MAHER-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Maher\n            ER\n          , Yates JR, Harries R, Benjamin C, Harris R, Moore AT & Ferguson-Smith MA 1990 Clinical features and natural history of von Hippel-Lindau disease. Quarterly Journal of Medicine771151\u20131163.","DOI":"10.1093\/qjmed\/77.2.1151"},{"key":"2026070905580032600_MAHER-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Maher\n            ER\n          , Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA & Morton N 1991 Von Hippel-Lindau disease: a genetic study. Journal of Medical Genetics28443\u2013447.","DOI":"10.1136\/jmg.28.7.443"},{"key":"2026070905580032600_MAHER-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Maher\n            ER\n          , Webster AR, Richards FM, Green JS, Crossey PA, Payne SJ & Moore AT 1996 Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. Journal of Medical Genetics33328\u2013332.","DOI":"10.1136\/jmg.33.4.328"},{"key":"2026070905580032600_MANSKI-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Manski\n            TJ\n          , Heffner DK, Glenn GM, Patronas NJ, Pikus AT, Katz D, Lebovics R, Sledjeski K, Choyke PL, Zbar B et al.1997 Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. Journal of the American Medical Association2771461\u20131466.","DOI":"10.1001\/jama.1997.03540420057030"},{"key":"2026070905580032600_MARANCHIE-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Maranchie\n            JK\n          , Vasselli JR, Riss J, Bonifacino JS, Linehan WM & Klausner RD 2002 The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma. Cancer Cell1257\u2013255.","DOI":"10.1016\/S1535-6108(02)00044-2"},{"key":"2026070905580032600_MARCOS-ETAL-2002","doi-asserted-by":"crossref","unstructured":"Marcos\n            HB\n          , Libutti SK, Alexander HR, Lubensky IA, Bartlett DL, Walther McCM, Linehan WM, Glenn GM& Choyke PL 2002 Neuroendocrine tumours of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison. Radiology225751\u2013758.","DOI":"10.1148\/radiol.2253011297"},{"key":"2026070905580032600_MASSON-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Masson\n            N\n          , Willam C, Maxwell PH, Pugh CW & Ratcliffe PJ 2001 Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO Journal205197\u20135206.","DOI":"10.1093\/emboj\/20.18.5197"},{"key":"2026070905580032600_MAXWELL-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Maxwell\n            PH\n          , Wiesener MS, Chang GT-W, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER & Ratcliff PJ 1999 The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature399271\u2013275.","DOI":"10.1038\/20459"},{"key":"2026070905580032600_NEUMANN-ETAL-1991","doi-asserted-by":"crossref","unstructured":"Neumann\n            HP\n          , Dinkel E, Brambs H, Wimmer B, Friedburg H, Volk B, Sigmund G, Riegler P, Haag K, Schollmeyer P et al.1991 Pancreatic lesions in the von Hippel-Lindau syndrome. Gastroenterology101465\u2013471.","DOI":"10.1016\/0016-5085(91)90026-H"},{"key":"2026070905580032600_NEUMANN-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Neumann\n            HP\n          , Eng C, Mulligan LM, Glavac D, Zauner I, Ponder BA, Crossey PA, Maher ER & Brauch H 1995 Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II. Journal of the American Medical Association2741149\u20131151.","DOI":"10.1001\/jama.1995.03530140061033"},{"key":"2026070905580032600_NEUMANN-ETAL-2002","unstructured":"Neumann\n            HPH\n          , Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoeffer C, Zerres K et al.2002 Germline mutations in nonsyndromic phaeochromocytoma. New England Journal of Medicine3461459\u20131466."},{"key":"2026070905580032600_NIEMANN-AND-MULLER-2000","unstructured":"Niemann\n            S\n           & Muller U 2000 Mutations in SDHC cause autosomal dominant paraganglioma. Nature Genetics26141\u2013150."},{"key":"2026070905580032600_OHH-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Ohh\n            M\n          , Yauch RL, Lonergan KM, Whaley JM, Stemmer Rachamimov AO, Louis DN, Gavin BJ, Kley N, Kaelin WG Jr & Iliopoulos O 1998 The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. Molecular Cell1959\u2013968.","DOI":"10.1016\/S1097-2765(00)80096-9"},{"key":"2026070905580032600_PASTORE-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Pastore\n            Y\n          , Jedlickova K, Guan Y, Liu E, Fahner J, Hasle H, Prchal JF & Prchal JT 2003 Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia. American Journal of Human Genetics73412\u2013419.","DOI":"10.1086\/377108"},{"key":"2026070905580032600_PAUSE-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Pause\n            A\n          , Lee S, Worrell RA, Chen DYT, Burgess WH, Linehan WM & Klausner RD 1997 The von Hippel- Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins. PNAS942156\u20132161.","DOI":"10.1073\/pnas.94.6.2156"},{"key":"2026070905580032600_PIOLI-AND-RIGBY-2001","doi-asserted-by":"crossref","unstructured":"Pioli\n            PA\n           & Rigby WF 2001 The von Hippel-Lindau protein interacts with heteronuclear ribonucleoprotein a2 and regulates its expression. Journal of Biological Chemistry27640346\u201344052.","DOI":"10.1074\/jbc.M105391200"},{"key":"2026070905580032600_POLLARD-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Pollard\n            PJ\n          , Briere JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ et al.2005 Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Human Molecular Genetics142231\u20132239.","DOI":"10.1093\/hmg\/ddi227"},{"key":"2026070905580032600_PROWSE-ETAL-1997","unstructured":"Prowse\n            AH\n          , Webster AR, Richards FM, Richard S, Olschwang S, Resche F, Affara NA & Maher ER 1997 Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. American Journal of Human Genetics60765\u2013771."},{"key":"2026070905580032600_RAVAL-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Raval\n            RR\n          , Lau KW, Tran MG, Sowter HM, Mandriota SJ, Li JL, Pugh CW, Maxwell PH, Harris AL & Ratcliffe PJ 2005 Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Molecular and Cellular Biology255675\u20135686.","DOI":"10.1128\/MCB.25.13.5675-5686.2005"},{"key":"2026070905580032600_RICHARDS-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Richards\n            FM\n          , Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA & Maher ER 1995 Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Human Molecular Genetics42139\u20132143.","DOI":"10.1093\/hmg\/4.11.2139"},{"key":"2026070905580032600_RICHARDS-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Richards\n            FM\n          , Schofield PN, Fleming S & Maher ER 1996 Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. Human Molecular Genetics5639\u2013644.","DOI":"10.1093\/hmg\/5.5.639"},{"key":"2026070905580032600_SCHLINGENSIEPEN-ETAL-1994","doi-asserted-by":"crossref","unstructured":"Schlingensiepen\n            KH\n          , Wollink F, Kunst M, Schlingensiepen R, Herdegen T & Brysch W 1994 The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo. Cellular and Molecular Neurobiology14487\u2013505.","DOI":"10.1007\/BF02088833"},{"key":"2026070905580032600_SCHOFIELD-AND-RATCLIFFE-2004","doi-asserted-by":"crossref","unstructured":"Schofield\n            CJ\n           & Ratcliffe PJ 2004 Oxygen sensing by HIF hydroxylases. Nature Reviews Molecular Cell Biology5343\u2013354.","DOI":"10.1038\/nrm1366"},{"key":"2026070905580032600_SELAK-ETAL-2005","doi-asserted-by":"crossref","unstructured":"Selak\n            MA\n          , Armour SA, Mackenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB & Gottlieb E 2005 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell777\u201385.","DOI":"10.1016\/j.ccr.2004.11.022"},{"key":"2026070905580032600_SGAMBATI-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Sgambati\n            MT\n          , Stolle C, Choyke PL, Walther MM, Zbar B, Linehan WM & Glenn GM 2000 Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. Americal Journal of Human Genetics6684\u201391.","DOI":"10.1086\/302726"},{"key":"2026070905580032600_STEBBINS-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Stebbins\n            CE\n          , Kaelin WG Jr & Pavletich NP 1999 Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Science284455\u2013461.","DOI":"10.2210\/pdb1vcb\/pdb"},{"key":"2026070905580032600_STRAUB-ETAL-2003","doi-asserted-by":"crossref","unstructured":"Straub\n            JA\n          , Lipscomb EA, Yoshuida ES & Freeman RS 2003 Induction of SM-20 in PC12 cells leads to increased cytochrome c levels, accumulation of cytochrome c in the cytosol, and caspase-dependent cell death. Journal of Neurochemistry85318\u2013328.","DOI":"10.1046\/j.1471-4159.2003.01688.x"},{"key":"2026070905580032600_VOGEL-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Vogel\n            KS\n          , Brannan CI, Jenkins NA, Copeland NG & Parad LF 1995 Loss of neurofibromin results in neurotrophin-independent survival of embryonic sensory and sympathetic neurons. Cell82733\u2013742.","DOI":"10.1016\/0092-8674(95)90470-0"},{"key":"2026070905580032600_WALTHER-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Walther\n            MM\n          , Retier R, Keiser HR, Choyke PL, Venzon D, Hurley K, Gnarra JR, Reynolds JC, Glenn GM & Zbar B 1999 Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. Journal of Urology162659\u2013664.","DOI":"10.1097\/00005392-199909010-00004"},{"key":"2026070905580032600_WEBSTER-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Webster\n            AR\n          , Richards FM, MacRonald FE, Moore AT & Maher ER 1998 An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. American Journal of Human Genetics631025\u20131035.","DOI":"10.1086\/302037"},{"key":"2026070905580032600_WIZIGMANN-VOOS-ETAL-1995","unstructured":"Wizigmann-Voos\n            S\n          , Breier G, Risau W & Plate KH 1995 Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Research551358\u20131364."},{"key":"2026070905580032600_WOODWARD-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Woodward\n            ER\n          , Eng C, McMahon R, Voutilainen R, Affara NA, Ponder BAJ & Maher ER 1997 Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL. Human Molecular Genetics61051\u20131056.","DOI":"10.1093\/hmg\/6.7.1051"},{"key":"2026070905580032600_XIA-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Xia\n            Z\n          , Dickens M, Raingeaud J, Davis RJ & Greenberg ME 1995 Opposing effects of ERK and JNK-p38 MAP kinases in apoptosis. Science2701326\u20131331.","DOI":"10.1126\/science.270.5240.1326"},{"key":"2026070905580032600_YU-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Yu\n            F\n          , White SB, Zhao Q & Lee FS 2001 HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. PNAS989630\u20139635.","DOI":"10.1073\/pnas.181341498"},{"key":"2026070905580032600_ZBAR-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Zbar\n            B\n          , Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, Crossey PA, Webster AR, Affara NA, Ferguson- Smith MA et al.1996 Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Human Mutation8348\u2013357.","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/13\/2\/0130415.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/13\/2\/415\/150044\/0130415.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/13\/2\/415\/150044\/0130415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T09:58:16Z","timestamp":1783591096000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/13\/2\/415\/26703\/Von-Hippel-Lindau-disease-and-endocrine-tumour"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6,1]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6,1]]}},"URL":"https:\/\/doi.org\/10.1677\/erc.1.00683","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6,1]]}}}